These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1449724)

  • 21. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC).
    Rosenblatt S; Bassuk JA; Alpers CE; Sage EH; Timpl R; Preissner KT
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):311-9. PubMed ID: 9164872
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies.
    Sweetwyne MT; Brekken RA; Workman G; Bradshaw AD; Carbon J; Siadak AW; Murri C; Sage EH
    J Histochem Cytochem; 2004 Jun; 52(6):723-33. PubMed ID: 15150281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SPARC inhibits endothelial cell adhesion but not proliferation through a tyrosine phosphorylation-dependent pathway.
    Motamed K; Sage EH
    J Cell Biochem; 1998 Sep; 70(4):543-52. PubMed ID: 9712151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of endothelial cell shape by SPARC does not involve chelation of extracellular Ca2+ and Mg2+.
    Sage EH
    Biochem Cell Biol; 1992 Jan; 70(1):56-62. PubMed ID: 1581032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
    Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
    Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of extracellular proteins is correlated with angiogenesis in vitro.
    Iruela-Arispe ML; Hasselaar P; Sage H
    Lab Invest; 1991 Feb; 64(2):174-86. PubMed ID: 1705300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand.
    Yost JC; Sage EH
    J Biol Chem; 1993 Dec; 268(34):25790-6. PubMed ID: 8245016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and purification of recombinant human SPARC produced by baculovirus.
    Bradshaw AD; Bassuk JA; Francki A; Sage EH
    Mol Cell Biol Res Commun; 2000 Jun; 3(6):345-51. PubMed ID: 11032756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of human monocyte matrix metalloproteinases by SPARC.
    Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
    J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenes in the study of endothelial cell growth and differentiation.
    Wagner EF; Risau W
    Semin Cancer Biol; 1994 Apr; 5(2):137-45. PubMed ID: 7520302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function.
    Goldblum SE; Ding X; Funk SE; Sage EH
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3448-52. PubMed ID: 8159767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases.
    Taraboletti G; Garofalo A; Belotti D; Drudis T; Borsotti P; Scanziani E; Brown PD; Giavazzi R
    J Natl Cancer Inst; 1995 Feb; 87(4):293-8. PubMed ID: 7535861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human endothelial cells expressing polyoma middle T induce tumors.
    Primo L; Roca C; Ferrandi C; Lanfrancone L; Bussolino F
    Oncogene; 2000 Jul; 19(32):3632-41. PubMed ID: 10951569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
    Lane TF; Sage EH
    J Cell Biol; 1990 Dec; 111(6 Pt 2):3065-76. PubMed ID: 2269665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPARC: a Ca2+-binding extracellular protein associated with endothelial cell injury and proliferation.
    Sage H; Decker J; Funk S; Chow M
    J Mol Cell Cardiol; 1989 Feb; 21 Suppl 1():13-22. PubMed ID: 2733023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
    Goto F; Goto K; Weindel K; Folkman J
    Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
    Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
    Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of extracellular matrix proteins by endothelial cells undergoing angiogenesis in vitro.
    Iruela-Arispe ML; Diglio CA; Sage EH
    Arterioscler Thromb; 1991; 11(4):805-15. PubMed ID: 1712229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo.
    Vial E; Castellazzi M
    Oncogene; 2000 Mar; 19(14):1772-82. PubMed ID: 10777211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPARC modulates cell growth, attachment and migration of U87 glioma cells on brain extracellular matrix proteins.
    Rempel SA; Golembieski WA; Fisher JL; Maile M; Nakeff A
    J Neurooncol; 2001 Jun; 53(2):149-60. PubMed ID: 11716067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.